The --491 TT apolipoprotein E promoter polymorphism is associated with reduced risk for sporadic Alzheimer's disease. (Q53346508)

13 May 2018

title

The --491 TT apolipoprotein E promoter polymorphism is associated with reduced risk for sporadic Alzheimer's disease. (English)

1 reference

13 May 2018

0 references

Alvarez-Arcaya A

1

1 reference

13 May 2018

Combarros O

2

1 reference

13 May 2018

Llorca J

3

1 reference

13 May 2018

Sánchez-Guerra M

4

1 reference

13 May 2018

Berciano J

5

1 reference

13 May 2018

Fernández-Luna JL

6

1 reference

13 May 2018

language of work or name

English

0 references

publication date

1 May 2001

1 reference

13 May 2018

published in

Neuroscience Letters

1 reference

13 May 2018

volume

304

1 reference

13 May 2018

issue

3

1 reference

13 May 2018

page(s)

204-208

1 reference

13 May 2018

The -491A/T polymorphism of the Apolipoprotein E gene is associated with the ApoEepsilon4 allele and Alzheimer's disease.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901790-6

7 January 2021

Risk for Alzheimer's disease correlates with transcriptional activity of the APOE gene.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901790-6

7 January 2021

Allelic polymorphisms in the transcriptional regulatory region of apolipoprotein E gene

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901790-6

7 January 2021

Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901790-6

7 January 2021

A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901790-6

7 January 2021

APOE-491 promoter polymorphism is a risk factor for late-onset Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901790-6

7 January 2021

Apolipoprotein E promoter and alpha2-macroglobulin polymorphisms are not genetically associated with Chinese late onset Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901790-6

7 January 2021

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901790-6

7 January 2021

Promoter polymorphism (-491A/T) in the APOE gene of Finnish Alzheimer's disease patients and control individuals.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901790-6

7 January 2021

Distortion of allelic expression of apolipoprotein E in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901790-6

7 January 2021

Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901790-6

7 January 2021

A new polymorphism in the APOE promoter associated with risk of developing Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901790-6

7 January 2021

The -491AA polymorphism in the APOE gene is associated with increased plasma apoE levels in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901790-6

7 January 2021

A newly identified polymorphism in the apolipoprotein E enhancer gene region is associated with Alzheimer's disease and strongly with the epsilon 4 allele

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901790-6

7 January 2021

The -491 A/T polymorphism in the regulatory region of the apolipoprotein E gene and early-onset Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901790-6

7 January 2021

Absence of association between Alzheimer disease and the -491 regulatory region polymorphism of APOE.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901790-6

7 January 2021

Increased plasma apolipoprotein E (apoE) levels in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901790-6

7 January 2021

Polymorphisms of the human apolipoprotein E promoter and bleomycin hydrolase gene: risk factors for Alzheimer's dementia?

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901790-6

7 January 2021

Apolipoprotein E promoter polymorphism and sporadic Alzheimer's disease in a Japanese population.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901790-6

7 January 2021

The -491A/T apolipoprotein E promoter polymorphism association with Alzheimer's disease: independent risk and linkage disequilibrium with the known APOE polymorphism.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901790-6

7 January 2021

Effect of APOE genotype and promoter polymorphism on risk of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901790-6

7 January 2021

APOE promoter polymorphisms do not confer independent risk for Alzheimer's disease in a French population.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901790-6

7 January 2021

10.1016/S0304-3940(01)01790-6

Identifiers

DOI

1 reference

13 May 2018

PubMed ID

11343837

1 reference

13 May 2018